4 days ago
6
Neha Chamaria, The Motley Fool
Sun, January 4, 2026 astatine 2:08 PM CST 6 min read
-
SCHD charges a overmuch little disbursal ratio and pays a higher dividend output than NOBL.
-
SCHD has outperformed NOBL successful presumption of full returns implicit the past 5 and 10 years, though some saw akin drawdowns.
-
SCHD holds much stocks and leans much into vigor and healthcare, portion NOBL emphasizes industrials and user antiaircraft companies.
-
These 10 stocks could mint the adjacent question of millionaires ›
Want regular and bankable dividends without having to analyse and put successful stocks? Consider ProShares S&P 500 Dividend Aristocrats ETF (NYSEMKT:NOBL) and Schwab U.S. Dividend Equity ETF (NYSEMKT:SCHD). Both these exchange-traded funds people dividend-focused U.S. stocks, offering investors an casual mode to summation vulnerability to dividend stocks. However, the methodologies and holdings of these 2 ETFs make noticeable differences.
These 2 ETFs disagree the astir successful presumption of cost, yield, and assemblage approach, with SCHD offering little fees and a higher dividend payout. NOBL tilts much toward industrials but offers vulnerability to apical dividend maturation stocks. Investors comparing these ETFs whitethorn privation to measurement caller returns, hazard profiles, and assemblage exposures, arsenic good arsenic header metrics specified arsenic outgo and output earlier deciding which 1 to buy.
| Issuer | ProShares | Schwab |
| Expense ratio | 0.35% | 0.06% |
| 1-yr full instrumentality (as of Dec. 31, 2025) | 6.8% | 4.3% |
| Dividend yield | 2.2% | 3.8% |
| AUM | $11.3 billion | $72.5 billion |
Beta measures terms volatility comparative to the S&P 500; beta is calculated from five-year play returns. The 1-yr instrumentality represents full instrumentality implicit the trailing 12 months.
SCHD is much affordable with a 0.06% disbursal ratio compared to NOBL’s 0.35%, and it presently pays retired a notably higher dividend yield, which whitethorn entreaty to income-oriented investors.
| Max drawdown (5 y) | (17.91%) | (16.82%) |
| Growth of $1,000 implicit 5 years | $1,308 | $1,298 |
The Schwab U.S. Dividend Equity ETF tracks a handbasket of 102 ample U.S. dividend stocks, with a assemblage premix that skews toward vigor (19.3%), user staples (18.5%), and healthcare (16.1%). Its apical holdings see Bristol Myers Squibb (NYSE:BMY). Merck & Co (NYSE:MRK), and ConocoPhillips (NYSE:COP). The money has a 14.2-year way record, providing immoderate humanities position connected its attack and payout consistency.
The ProShares S&P 500 Dividend Aristocrats ETF, connected the different hand, focuses connected S&P 500 companies with astatine slightest 25 consecutive years of dividend growth, resulting successful a lineup of 70 stocks. It leans astir heavy connected industrials (22.4%), user antiaircraft (22%), and fiscal services (12.4%). The largest 3 positions see Albemarle (NYSE:ALB), Cardinal Health (NYSE:CAH), and C.H. Robinson Worldwide (NASDAQ:CHRW).
English (CA) · 
English (US) · 
Spanish (MX) ·